This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Allurion Technologies’s 8K filing here.
About Allurion Technologies
Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
See Also
- Five stocks we like better than Allurion Technologies
- EV Stocks and How to Profit from Them
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- What is the Hang Seng index?
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
